Omalizumab effect on eosinophilic otitis media and sinusitis: A case report

Hidetoshi Oshima, Toshimitsu Kobayashi, Tetsuaki Kawase

研究成果: Article査読

抄録

Omalizumab, a monoclonal antibody to human IgE, is used to treat severe asthma and is reportedly effective in other allergic diseases. We report a case of eosinophilic otitis media and sinusitis improved by omalizumab treatment. A 66-year-old woman with severe asthma, eosinophilic otitis media, and sinusitis had omalizumab started to treat asthma. Besides rapidly improving asthma symptoms, it ameliorated eosinophilic otitis media and sinusitis, confirming its hoped for effectiveness.

本文言語English
ページ(範囲)319-323
ページ数5
ジャーナルPractica Oto-Rhino-Laryngologica
104
5
DOI
出版ステータスPublished - 2011 5 1

ASJC Scopus subject areas

  • 耳鼻咽喉科学

フィンガープリント

「Omalizumab effect on eosinophilic otitis media and sinusitis: A case report」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル